{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:10:07Z","timestamp":1791148207548,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>In an effort to implicate immune responses to specific<jats:italic>Borrelia burgdorferi<\/jats:italic>proteins that may have a role in chronic Lyme arthritis, we studied the natural history of the antibody response to<jats:italic>B. burgdorferi<\/jats:italic>in serial serum samples from 25 patients monitored throughout the course of Lyme disease. In these patients, the immunoglobulin G (IgM) and IgG antibody responses to 10 recombinant<jats:italic>B. burgdorferi<\/jats:italic>proteins, determined during early infection, early arthritis, and maximal arthritis, were correlated with the severity and duration of maximal arthritis. The earliest responses were usually to outer surface protein C (OspC), P35, P37, and P41; reactivity with OspE, OspF, P39, and P93 often developed weeks later; and months to years later, 64% of patients had responses to OspA and OspB. During early infection and early arthritis, the levels of IgG antibody to P35 correlated inversely with the subsequent severity or duration of maximal arthritis. In contrast, during periods of maximal arthritis, the levels of IgG antibody to OspA and OspB, especially to a C-terminal epitope of OspA, correlated directly with the severity and duration of arthritis. Thus, the higher the IgG antibody response to P35 earlier in the infection, the milder and briefer the subsequent arthritis, whereas during maximal arthritis, the higher the IgG response to OspA and OspB, the more severe and prolonged the arthritis.<\/jats:p>","DOI":"10.1128\/iai.67.1.173-181.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:29:49Z","timestamp":1577806189000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":115,"title":["The Immunoglobulin (IgG) Antibody Response to OspA and OspB Correlates with Severe and Prolonged Lyme Arthritis and the IgG Response to P35 Correlates with Mild and Brief Arthritis"],"prefix":"10.1128","volume":"67","author":[{"given":"Evren","family":"Akin","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Divisions of Rheumatology\/Immunology and Pediatric Rheumatology1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail L.","family":"McHugh","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Rheumatology\/Immunology,2 Tufts University School of Medicine, New England Medical Center, Tupper Research Institute, Boston, Massachusetts, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Flavell","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Howard Hughes Medical Institute3 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Division of Rheumatology,4 Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Rheumatology\/Immunology,2 Tufts University School of Medicine, New England Medical Center, Tupper Research Institute, Boston, Massachusetts, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2325"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110998"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.45.1.94-100.1984"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.41.2.795-804.1983"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1989.tb00194.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.4.983-991.1990"},{"key":"e_1_3_2_8_2","first-page":"19","article-title":"Case definitions for public health surveillance","volume":"39","author":"Centers for Disease Control","year":"1990","unstructured":"Centers for Disease Control Case definitions for public health surveillance.Morbid. Mortal. Weekly Rep.3919901921","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_9_2","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on the Serological Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","unstructured":"Centers for Disease Control and Prevention Recommendations for test performance and interpretation from the Second National Conference on the Serological Diagnosis of Lyme Disease.Morbid. Mortal. Weekly Rep.441995590591","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112683"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119264"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.2.392"},{"key":"e_1_3_2_13_2","first-page":"734","article-title":"Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting","volume":"20","author":"Fawcett P. T.","year":"1993","unstructured":"Fawcett P. T. Rose C. Gibney K. M. Chase C. A. Kiehl B. Doughty R. A. Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting.J. Rheum.201993734738","journal-title":"J. Rheum."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2237407"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80341-6"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.4049\/jimmunol.155.12.5700","article-title":"An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies","volume":"155","author":"Fikrig E.","year":"1995","unstructured":"Fikrig E. Liu B. Fu L. L. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies.J. Immunol.155199557005704","journal-title":"J. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.5.1658-1662.1995"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5418"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/37551"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.8.3213-3221.1994"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5377.703"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3969554"},{"key":"e_1_3_2_23_2","first-page":"26","article-title":"Lyme arthritis: spirochetes found in synovial microangiopathic lesions","volume":"118","author":"Johnston Y. E.","year":"1985","unstructured":"Johnston Y. E. Duray P. H. Steere A. C. Kashgarian M. Buza J. Malawista S. E. Askenase P. W. Lyme arthritis: spirochetes found in synovial microangiopathic lesions.Am. J. Pathol.11819852634","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.7.2774-2779.1993"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.6.2228-2235.1995"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.1.290-298.1994"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2069"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.10.4309-4321.1992"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(95)99915-9"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300401"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.11.4662-4672.1992"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.7.1733-1738.1994"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.01127.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.3.629-635.1993"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1324"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119589"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117346"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.2909"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.4049\/jimmunol.147.6.1995","article-title":"Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease","volume":"147","author":"Sears J. E.","year":"1991","unstructured":"Sears J. E. Fikrig E. Nakagawa T. Y. Deponte K. Marcantonio N. Kantor F. S. Flavell R. A. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.J. Immunol.147199119952000","journal-title":"J. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.6.1329-1337.1990"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-1-76"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310405"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007263230402"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370616"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-5-725"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390401"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.67.1.173-181.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.67.1.173-181.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T14:37:02Z","timestamp":1695566222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.67.1.173-181.1999"}},"subtitle":[],"editor":[{"given":"J. R.","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1128\/IAI.67.1.173-181.1999"],"URL":"https:\/\/doi.org\/10.1128\/iai.67.1.173-181.1999","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"1998-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-09-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}